Lyo-Modelling Reduce risks on the road to commercialization through process understanding

July 10th, 2024 – 4pm (CET) / 10am (ET)

Lyo-Modelling Reduce risks on the road to commercialization through process understanding

July 10th, 2024 – 4pm (CET) / 10am (ET)

Addressed Challenges

  • Intra-batch variability within a lyophilization process
  • Robustness of lyophilization processes
  • Primary drying process optimization

What You Will Learn

  • Balance between process speed and product quality
  • Statistical Model Approaches in Lyo process optimization
  • Major process failures in the primary drying phase

Prof. Dr. Wolfgang Frieß

Ludwig-Maximilians-Universitaet Muenchen Department of Pharmacy – Center for Drug Research Pharmaceutical Technology and Biopharmaceutics

Prof. Dr. Wolfgang Frieß is an expert in protein formulation development, stability, and processing, drying technologies including freeze-drying and spray-drying as well as drug delivery. Since 2001 he is a professor for Pharmaceutical Technology and Biopharmaceutics at the LMU Munich. Prof. Dr. Wolfgang Frieß has collected more than 30 years of experience in pharmaceutical technology while working at the University of Erlangen (Germany), Genetics Institute – now Pfizer (Andover, MA, USA), and the University of Illinois (Chicago, IL, USA). Prof. Dr. Wolfgang Frieß is the co-editor of the EJPB (European Journal of Pharmaceutics and Biopharmaceutics) and has published over 150 research papers, patents, and book chapters.
Read More >>>

Dr. Brecht Vanbillemont

Senior Scientist, Coriolis Pharma

Dr. Brecht Vanbillemont, a senior scientist at Coriolis Pharma in Munich, Germany, specialized in lyophilization process and formulation development. Dr. Vanbillemont is a licensed pharmacist and qualified person. He has directed numerous CRO development studies across various modalities. Dr. Vanbillemont oversees the different aspects of drug product development, from formulation screening to process optimization and late-phase robustness studies. He holds a doctoral degree from Ghent University, where his research focused on continuous freeze-drying of parenterals and orally disintegrating tablets under the guidance of Prof. Thomas De Beer. He has authored 18 scientific publications and presented at numerous international conferences. Dr. Vanbillemont was a visiting scholar for 6 months at the University of Colorado, mentored by Prof. John Carpenter, further enriching his expertise in the field.
Read More >>>

<span>By ticking this box, you agree to the privacy policies of <a href=”https://www.coriolis-pharma.com/data-privacy/” style=”color:white; text-decoration: underline;” target=”_blank”>Coriolis Pharma</a> and <a href=”/wp-content/uploads/2023/08/Livestorm-privacy-policy-en.pdf” style=”color:white; text-decoration: underline;” target=”_blank”>Livestorm</a>, consenting to receiving communications related to this topic and other products or services within their portfolio</span>

Dark